You are here
- Home
- Drug Products
- All Drug Products
A Phase I, Open-label, Single-Centre Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous Administration to Healthy Male Subjects
- Disease
- depressive disorder
- Drug Name
- AZD6765
- Generic Name
- AZD6765
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Sep 8, 2010
- Study Name
- D6702C00030
- Study Id
- D6702C00030
- ClinicalTrials.gov ID
- NCT01217645
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
